V ariable diversity joining recombination is a site-specific recombination process that leads to the creation of a novel immune receptor gene repertoire (1). Recombination is crucial for lymphoid development, and aberrant regulation of this process may lead to immune deficiency or promote tumorigenesis. Recombination is initiated by the recombinase-activating gene products RAG-1 and RAG-2. The RAG dimer recognizes and specifically cleaves recombination signal sequences that flank immune receptor gene segments. The recombination process is tightly regulated in a stage-and lineage-specific manner. This level of control cannot be explained simply by the presence or absence of the RAG recombinase. Thus it had been postulated that access of the V(D)J recombinase to its target sequence is regulated and that chromatin modifications similar to those required for transcriptional processes participate in this regulation (2, 3). In support of this hypothesis, it was reported that transcription of unrearranged gene segments usually precedes V(D)J recombination and the absence of transcriptional regulatory sequences within the TCR locus results in inhibition of recombination. Thus, an open chromatin structure may allow access of the transcriptional machinery as well as access for the V(D)J recombinase. Recently it was reported that targeted deletion of regulatory sequences of the TCR␣ and ␤ locus that abrogate recombination correlates with the level of histone acetylation (4, 5). This suggests another close relationship between the regulation of chromatin accessibility for transcription as well as the process of V(D)J recombination.
V ariable diversity joining recombination is a site-specific recombination process that leads to the creation of a novel immune receptor gene repertoire (1) . Recombination is crucial for lymphoid development, and aberrant regulation of this process may lead to immune deficiency or promote tumorigenesis. Recombination is initiated by the recombinase-activating gene products RAG-1 and RAG-2. The RAG dimer recognizes and specifically cleaves recombination signal sequences that flank immune receptor gene segments. The recombination process is tightly regulated in a stage-and lineage-specific manner. This level of control cannot be explained simply by the presence or absence of the RAG recombinase. Thus it had been postulated that access of the V(D)J recombinase to its target sequence is regulated and that chromatin modifications similar to those required for transcriptional processes participate in this regulation (2, 3) . In support of this hypothesis, it was reported that transcription of unrearranged gene segments usually precedes V(D)J recombination and the absence of transcriptional regulatory sequences within the TCR locus results in inhibition of recombination. Thus, an open chromatin structure may allow access of the transcriptional machinery as well as access for the V(D)J recombinase. Recently it was reported that targeted deletion of regulatory sequences of the TCR␣ and ␤ locus that abrogate recombination correlates with the level of histone acetylation (4, 5) . This suggests another close relationship between the regulation of chromatin accessibility for transcription as well as the process of V(D)J recombination.
IL-7 is required for normal lymphoid development and specifically for V(D)J recombination at the TCR␥ locus (reviewed in Refs. 6 -8) . Deletion of different components of the IL-7 signal transduction pathway inhibits ␥␦ T cell development and leads to a specific suppression of V(D)J recombination at the TCR␥ locus (9 -12) . Although IL-7 provides survival functions for pro-T cells, the defect in recombination cannot be corrected by substituting the IL-7 signal with a survival signal. Thus a bcl-2 transgene did not restore V(D)J recombination at the TCR␥ locus in IL-7R␣ Ϫ/Ϫ mice (12) . We have previously reported that in the absence of the IL-7R␣ signal, T cell precursors fail to initiate cleavage at the TCR␥ locus and that this failure is due to an inaccessible state of chromatin for RAG-mediated cleavage (13, 14) . The need for the IL-7R␣ signal can be replaced by Trichostatin A, a specific inhibitor of histone deacetylases, suggesting a role of histone acetylation in the opening of chromatin structure induced by IL-7. However, Trichostatin A treatment induces a global, rather than locus-specific, acetylation of histones, and thus its mechanism of mimicking the IL-7 effect on the TCR␥ locus might have been indirect. Thus, in the present study we address the question of how IL-7 signaling modifies chromatin to allow access for the V(D)J recombinase. We examined whether IL-7 induces specifically histone acetylation directly at regulatory sites within the TCR␥ locus.
Materials and Methods

Mice
Embryonic thymus were derived from day 15 gestation of C57BL/6 mice (Animal Production, Frederick, MD). IL-7R␣ Ϫ/Ϫ mice and Rag-2 Ϫ/Ϫ mice (The Jackson Laboratory, Bar Harbor, ME) were ϳ4 -8 wk of age. The generation of IL-7 Ϫ/Ϫ Rag-1 Ϫ/Ϫ were kindly provided by R. Murray (EOS Biotechnology, San Francisco, CA) (9) . Animal care was provided in accordance with the procedures outlined in the "Guide for the Care and Use of Laboratory Animals" (National Institutes of Health Publication No. 1985) .
Primers and probes
The locations of primers and probes within the TCR␥ locus are shown in Fig. 1 . The primers for detection of gene rearrangement and sterile transcripts were derived from sequences as previously published (13, 14) . The following oligonucleotides were used in the chromatin immunoprecipitation (ChIP)
2 -PCR assay: 1) upstream: S:5Ј-GGCAAGAAACAGAA CAACTG-3Ј; AS:5Ј-GGACAATGTCTATTCTAGTC-3Ј; and probe: 5Ј-GTTCTGATTGGCTACTTTCC-3Ј. 2) V␥HsA: S5Ј-GCTCTCTCTCCC TTCTTTG-3Ј; AS5Ј-TGGTTGCAGACATGCTGAGTG-3Ј; and P5Ј-GGA AACACAAGACGTGACG-3Ј. 3) J␥ promoter: S5Ј-CCTCTTCTCAGAAA TATATCCCC-3Ј; AS5Ј-TAATTTCCAGGAACTCACTCGTG-3Ј; and P5Ј-ACATTGGTGCTTGTGAGAAC-3Ј. 4) Constant region enhancer: S5Ј-GTTGCTTCCTGGAAAATGGTTAAAG-3Ј; AS5Ј-CTAATAGCTGTGGT CTTTCGAAAG-3Ј; and P5Ј-AGGAGCAGTTAAACCACAGC-3Ј. 5) Downstream: S5Ј-AGGAGCTTCAGTTGAGGAAG-3Ј; AS5Ј-TAGAAC CAAGACTAACAGCC-3Ј; and P5Ј-CATGAGATCCAGCTGCAAGG3Ј. 6) ␦ Enhancer: S5Ј-CAAAATACATGCCCAGCCA-3Ј; AS 5ЈCAG CAAAACTGATAACCCC-3Ј; and P5Ј-AAGAGATAGCAGGG CTTCTG-3Ј. 7) Oct-2: S5Ј-TGGAGGAGCTGGAACAGTTTG-3Ј; AS 5ЈGGACCTTGGCATCTTTGTTCC-3Ј; and P5Ј-ATCAAGCTGGGCT TCACACAG-3Ј. 8) Pgk-2: S5Ј-TGAAGTAGAGCAAGCCTGTG-3Ј; AS 5ЈAGACAGTGATGCTTGGAAGG-3Ј; P5Ј-TGTGGAGGAAGAAGG TAAGG3Ј.
All these primer sets were designed to give a PCR product size ranging from 110 to 160 bp.
PCR and RT-PCR analysis
The PCR after ChIP was performed with Supermix (Life Technologies, Rockville, MD) started with 94°C for 5 min, followed by 25 cycles: 1 min at 94°C, 2 min at 51°C, and 3 min at 72°C, followed by a 10-min extension at 72°C. Total RNA was reverse transcribed with oligo(dT) primer by using Sensiscript Reverse Transcriptase (Qiagen, Valencia, CA) or a control reaction was performed omitting reverse transcriptase. PCR was amplified in 50 l of HotStartTaq Master Mix reaction buffer (Qiagen) containing 0.2 mM of each NTP, 0.2 M of each primer, and 2.5 U of HotStartTaq polymerase. The amplification for RT-PCR was started at 94°C for 15 min, followed by 35 cycles: 0.5 min at 94°C, 0.5 min at 56°C, and 1 min at 72°C, followed by a 10-min extension at 72°C. (The annealing temperature was 64°C for ␤-actin primers.) PCR products were separated by agarose gel electrophoresis and transferred to NYTRAN membranes (Schleicher & Schuell, Keene, NH). Hybridization was performed in Rapid-hyb buffer (Amersham Pharmacia Biotech, Piscataway, NJ) according to the manufacturer's protocol and visualized by autoradiography.
ChIPs assay
The procedure of chromatin immunoprecipitation was modified from the manufacturer's protocol (acetyl-histone H3 or H4 ChIP assay kit; Upstate Biotechnology, Lake Placid, NY) as follows. Thymocytes were crosslinked with 1% formaldehyde for 12 min at 37°C and the reaction was stopped by adding glycine to a final concentration of 125 mM for 5 min. The cells were washed twice in ice-cold PBS and lysed in SDS lysis buffer. Sonication was performed on ice and the samples were cooled on dry ice between the pulses, but care was taken not to freeze the samples. The length of the DNA fragments averaged between ϳ200 and 500 bp. After precleaning, 10% of each sample was saved as input fraction. Immunoprecipitation was performed using specific Abs against acetylated histone 3 (5 g/ml) and histone 4 (4 l/ml), or normal rabbit IgG (5 g/ml) as control. After incubation for 16 h at 4°C with agitation, the Ab/histone/ DNA complex was captured by using salmon sperm DNA/protein A-agarose slurry for 1 h rotating at 4°C. The supernatant of each sample was kept as unbound fraction. The complex was eluted and the cross-linking was reversed. After purification, the DNA concentration was determined and diluted in three-fold series (20 ng, 6.7 ng, and 2.33 ng) for PCR amplification. The blot result was imaged by PhosporImager and quantitated by ImageQuant v5.0 software (Molecular Dynamics, Sunnyvale, CA). The relative acetylated enrichment as shown in the figures was determined from the ratio of bound:input fractions which was very similar to the ratio formed by bound:unbound control fractions. The results shown in the figures are expressed as means Ϯ SE from three to five independent ChIP experiments.
Results and Discussion
Hyperacetylation of histones at the TCR␥ locus in normal fetal thymocytes
To determine whether IL-7 stimulation effects histone acetylation at the TCR␥ locus, we first determined the status of acetylation in the presence of IL-7 during normal development. TCR␥ locus rearrangement occurs in thymocytes between days 14 and 16 of murine gestation. During this period, sterile transcripts and recombination intermediates are detected, indicating an open chromatin configuration and an actively occurring recombination process, respectively (14) . Thus, fetal thymocytes were used as a nuclear source for ChIP using specific Abs against acetylated histones. The acetylation of N-terminal lysine residues of histone 3 as well as histone 4, components of the mononucleosomes, are thought to result in an open chromatin structure (2, 3, 15) . Fragmentation of chromatin after cross-linking allowed for specific analysis of small regulatory sequences (average size 200 -500 bp). The murine TCR␥1 locus extends 40 -50 kbp comprising four variable region gene segments and one joining and constant region segment (Fig. 1) . We first investigated the status of histone 3 and histone 4 acetylation at regulatory sites recently identified as transcriptional response elements within the TCR␥ locus: the DNase I hypersensitive site A (V-HsA), an enhancer-like element between the V5 and V2 genes, the J region promoter (J-promoter), or the constantregion enhancer (C-enhancer) (12, 16, 17) . In addition, the enhancer of the TCR␦ locus (E␦) was examined as a positive control. A representative ChIP experiment ( Fig. 2A) indicates specific acetylation at histone 3 as well as histone 4 for all three regulatory sites in comparison with the control immunoprecipitation. A critical question is whether this demonstrated acetylation level found at the TCR␥ locus is specifically elevated in comparison with other sites in the genome. To evaluate this question, the ratio was calculated between the specifically precipitated material and the input fraction and expressed as fold acetylation, as shown in Fig. 2B , summarizing five experiments. This ratio indicates how much a specific sequence is enriched in the precipitated fraction in comparison with the whole genome (Fig.  2B) . Thus the J-promoter, the C-enhancer, and the HsA sites are 22-, 10-, and 13-fold enriched in the acetylated H3 fraction and 35-, 15-, and 25-fold in the acetylated H4 fraction. This suggests a locus-specific enhancement of histone acetylation at the TCR␥ locus. In contrast, the tissue-specific expressed genes Oct-2 (B cell-specific) and Pgk-2 (testis-specific) are not enriched in the precipitated fraction, indicating no significant enhancement for acetylation in comparison with the overall genome. To determine the borders of hyperacetylation at the TCR␥ locus, we analyzed additional sequences that lack any known regulatory function. Whereas the upstream site (1300 bp upstream of V␥5) still showed a 4-fold enrichment (2-fold over Oct-2), the downstream sequence (1700 bp downstream of the C-enhancer) was indistinguishable in its H3 or H4 acetylation level from the control gene Oct-2. Thus the three known regulatory sites of the TCR␥ locus are hyperacetylated in comparison with the global genome and at least two other tissue-specific genes. Thus the acetylation is rather focused within the locus, tapering off with increasing distance from the regulatory sites.
Reduced histone acetylation at the TCR␥ locus in the absence of IL-7R␣ signaling
Next we addressed the question of whether hyperacetylation as observed at the TCR␥ locus during normal T cell development 2 Abbreviation used in this paper: ChIP, chromatin immunoprecipitation. 
14). Thus we compared the level of histone acetylation at the TCR␥ locus between IL-7R␣
Ϫ/Ϫ thymocytes and RAG Ϫ/Ϫ thymocytes. As shown in Fig. 3A , the level of histone acetylation was greatly reduced in the absence of IL-7R␣ signaling. The enrichment for acetylation in RAG Ϫ/Ϫ thymocytes was 20-, 26-, and 19-fold at J-promoter, C-enhancer, and V-HsA sites for H3 and 22-, 21-, and 16-fold for H4, and thus comparable with the hyperacetylation in fetal thymocytes (Fig. 3B) . The slight differences between RAG Ϫ/Ϫ and fetal thymocytes possibly reflect distinct developmental stages (the pro-T3 stage for RAG Ϫ/Ϫ thymocytes in contrast with the pro-T1/T2 stage for d14 fetal thymocytes). In both controls all three regulatory sites were markedly hyperacetylated. In contrast, the chromatin derived from IL-7R␣ Ϫ/Ϫ thymocytes showed an overall histone acetylation level indistinguishable from the control site within the Oct-2 gene. The reduction in acetylation was 12-to 22-fold for H3 and 6-to 10-fold for H4 comparing IL-7R␣ Ϫ/Ϫ with RAG Ϫ/Ϫ acetylation levels. Thus the specific histone acetylation at the regulatory sites within the TCR␥ locus that is observed during normal development is dependent on IL-7R␣ signaling.
Induction of sterile transcripts in IL-7
Ϫ/Ϫ RAG Ϫ/Ϫ thymocytes by IL-7 IL-7 is also an important survival signal for T cell precursors, although Bcl-2 cannot rescue the defective TCR␥ rearrangement in IL-7R␣ defective mice (12) . To determine whether IL-7 can directly effect accessibility at the TCR␥ locus instead of promoting accessibility indirectly through enhanced viability, we examined the induction of sterile transcripts. Transcription of unrearranged gene segments usually precedes V(D)J recombination and is considered an indicator of accessible chromatin. Previously we have reported that sterile transcripts are reduced in IL-7R␣ Ϫ/Ϫ thymocytes in contrast to RAG Ϫ/Ϫ thymocytes (13) (Fig. 4A) . We also detected a suppression of sterile transcripts for V␥2 and V␥3 and the constant region in IL-7 Ϫ/Ϫ RAG Ϫ/Ϫ thymocytes, indicating that at least part of the detrimental effect of IL-7R␣ deletion is due to IL-7 itself (rather than, for example, TSLP, which also binds IL-7R␣). Recently it had been reported that IL-7 can induce TCR␥ transcripts within 5 h in CD4 ϩ T cells purified from adult thymus (18) . Similarly, we were able to induce constant region transcripts in IL-7 Ϫ/Ϫ RAG Ϫ/Ϫ thymocytes within 5 h of stimulation with IL-7 in culture (Fig. 4A) . This rapid process suggests that IL-7 signaling is directly able to induce opening of chromatin in thymic precursors, rather than promoting cell survival or growth, indirectly affecting chromatin. We could not observe V␥ 2 and V␥3 transcripts in this time period, although the reduced acetylation levels at the HsA site would suggest a control by IL-7R␣ signaling as well. However, we observed reduced viability of IL-7
thymocytes over time in culture that was not restored by addition of additional cytokines such as stem cell factor. It remains possible that a different ligand of IL-7R␣, such as TSLP (19) , could provide long-term survival in culture or that TSLP may specifically participate in the control of V␥2 and V␥3 transcription. Recently it was reported that the histone acetylation levels at the recombination recognition sites at V␥2 and V␥3 are high in fetal thymocytes, as reported in this work, but distinctly regulated in adult thymocytes (being lower at V␥3) (20) . This suggests regulatory factors other than simply IL-7 alone being involved in the control of a FIGURE 2. Hyperacetylation of histone 3 and histone 4 during normal fetal development. A, Fetal thymocytes were immunoprecipitated using specific Abs against acetylated histone (AcH3) or acetylated histone 4 (AcH4), or using normal rabbit IgG (control). DNA from immunoprecipitates (bound), the supernatant (unbound), or the starting material (input) was serial diluted (1/3) for PCR analysis. Due to the limited amount of material, the PCR analysis and hybridization for the Oct-2 gene were not optimal in this particular experiment; however, other PCR analysis experiments verified that Oct-2 was usually detectable in the unbound material. B, Summary of five independent experiments using phosphor imaging analysis. The ratios represent DNA bound to acetylated H3 or H4 divided by input fraction. developmentally ordered rearrangement of the variable ␥ gene segments.
Histone acetylation at the TCR␥ locus is induced in IL-7
Ϫ/Ϫ RAG Ϫ/Ϫ thymocytes by IL-7
The induction of constant region transcripts by IL-7 within 5 h supports the idea that IL-7 directly effects chromatin accessibility at the TCR␥ locus. To determine whether histone acetylation contributes to the inducible opening of chromatin at the TCR␥ locus by IL-7 and to determine which regulatory sites are involved in this induction, ChIP experiments were performed. Fig. 4B summarizes a quantitative analysis of three independent ChIP experiments using thymocytes derived from IL-7 Ϫ/Ϫ RAG Ϫ/Ϫ mice and cultured with IL-7 in vitro for 5 h or left untreated. The level of H3 or H4 acetylation at the J-promoter or C-enhancer in untreated IL-7 Ϫ/Ϫ RAG Ϫ/Ϫ thymocytes was undistinguishable from the level observed at the Oct-2 gene. This underacetylation corresponds with the low acetylation level detected in IL-7R␣ Ϫ/Ϫ thymocytes. Within 5 h of IL-7 stimulation histone acetylation levels changed at the J-promoter and C-enhancer. Although the histone acetylation after stimulation with IL-7 was much smaller than that observed in wild-type thymocytes (see Fig. 2 ) the induction by IL-7 was threeto four-fold for H3 and H4 above the untreated control (Fig. 4B) . The J-promoter and the C-enhancer are thought to drive sterile constant region transcripts. Thus the induction of histone acetylation levels correlated closely with the induction of sterile transcripts. These results suggest that the IL-7 signal transduction pathway controls TCR␥ locus recombination by increasing acetylation of histones at specific cis-acting elements.
The precise signal transduction pathway leading from the IL-7R to the site of specific histone acetylation within the TCR␥ locus is not yet known, although the transcription factor Stat5 would be a candidate. IL-7 can activate Stat5, and there is strong evidence that Stat5 can induce histone acetylation. Moreover, Stat5 can bind to sequences within the J-promoter (the C-enhancer and V-HsA element contain potential binding sites) (12) . The most compelling evidence that Stat5 could mediate the observed acetylation effect comes from the report that a transgene expressing Stat5 restores TCR␥ recombination in IL-7R␣ deleted lymphoid precursor cells (12) . Stat5 has been demonstrated to associate with the interacting protein Nmi and with the histone acetylases CBP/P300 (21) . Thus activation of Stat5 by IL-7 could lead to site-specific recruitment of histone acetylases at the TCR␥ locus. In contrast, knockout of Stat5a/b was not reported to be deficient in ␥␦ T cells, implicating additional mediators.
How can site-specific histone acetylation regulate V(D)J recombination? Previous work suggested that mononucleosomes could inhibit RAG-mediated cleavage in vitro (22, 23) . This inhibition is thought to be caused by inhibiting access of the RAG dimer to the recombination signal sequence as well as to reducing cleavage capacity of the RAG recombinase (23) . How can histone acetylation overcome this suppression? Acetylation of histone tails may affect the structure of the mononucleosome or participate in unfolding of higher chromatin structure. Acetylated histone tails may also serve as flags for recruitment of other chromatin remodeling complexes. ATP-dependent complexes such as SWI/SNF complexes may disrupt chromatin structures by sliding mononucleosomes along the DNA, thus providing better access for the RAG recombinase. In support of this model, it was recently reported that both acetylation and SWI/SNF-dependent chromatin remodeling act in concert to promote RAG-mediated cleavage in vitro (23) . However, it is not yet known whether SWI/SNF-dependent remodeling contributes in vivo to accessibility for V(D)J recombination or whether other recombination-specific chromatin remodeling activities exist. The use of IL-7 to induce specifically TCR␥ rearrangement may serve as a valuable in vivo model to study the molecular mechanism for control of chromatin accessibility for V(D)J recombination.
